-
Mashup Score: 1cAttendee - 8 month(s) agoSource: cattendee.abstractsonline.comCategories: Hematologists1, Latest HeadlinesTweet
-
Mashup Score: 5cAttendee - 8 month(s) agoSource: cattendee.abstractsonline.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Join us for Marianna Brandao's oral presentation today from 3:22 PM to 3:32 PM (UTC+8) at the 2023 World Conference on Lung Cancer in Singapore. 👉 https://t.co/TeUYsBBTdI @IASLC #WCLC23 #CancerResearch #ClinicalTrials #LungCancer #Oncology https://t.co/thdoIAHhfF
-
-
Mashup Score: 0cAttendee - 8 month(s) agoSource: cattendee.abstractsonline.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Don't miss Dr. Ilias Houda's oral presentation today from 3:02 PM to 3:12 PM (UTC+8) at the 2023 World Conference on Lung Cancer in Singapore. https://t.co/TeUYsBBTdI @IASLC #WCLC23 #CancerResearch #ClinicalTrials #LungCancer #Oncology https://t.co/qt8k9tUjhO
-
-
Mashup Score: 0cAttendee - 8 month(s) agoSource: cattendee.abstractsonline.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
#WCLC23: Dr. @JBaldonadoMD discusses meeting the quality metric for minimum lymph node harvest for robotic lobectomy for lung cancer. 💻: On-demand presentation Learn More ➡️ https://t.co/OUrlO6rLYQ https://t.co/PWVix9n2ps
-
-
Mashup Score: 2cAttendee - 8 month(s) agoSource: cattendee.abstractsonline.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
#WCLC23: Dr. Bushra Shariff discusses the retrospective study on outcomes and treatment options for patients with NSCLC progression after treatment with Durvalumab. 💻: On-demand presentation Learn More ➡️ https://t.co/Qg6kZBmU5S https://t.co/wlXlL0VTF7
-
-
Mashup Score: 3cAttendee - 8 month(s) agoSource: cattendee.abstractsonline.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
✨Thrilled to announce that EORTC is participating in #WCLC23 in Singapore with 5 abstracts: 3 poster sessions and 2 oral presentations. 👉 https://t.co/nh1wFn6W6O @IASLC #CancerResearch #ClinicalTrials #LungCancer #Oncology https://t.co/YURiIDIhtk
-
-
Mashup Score: 1cAttendee - 8 month(s) agoSource: cattendee.abstractsonline.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
HRH Princess @dinamired of Jordan, Honorary President of the EORTC Cancer Research Fund, will be speaking at the #WCLC23 Opening Plenary Session. Don't miss it. More info: https://t.co/AYjdhDyRIk #CancerResearch #LungCancer #Oncology #ClinicalTrials https://t.co/d514kFLEqv
-
-
Mashup Score: 0cAttendee - 1 year(s) agoSource: cattendee.abstractsonline.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Sessions from #ESMOGynae23 are still available on the virtual platform - so if you missed a great scientific or educational moment from the programme head over here 🔗 https://t.co/TPaqwk6icZ #ovariancancer #cervicalcancer #endometrialcancer #GynCSM #gynaecologicalcancers https://t.co/WTmv5eNFtM
-
-
Mashup Score: 1cAttendee - 1 year(s) agoSource: cattendee.abstractsonline.comCategories: Latest Headlines, Oncologists1Tweet
-
Ongoing Updates in the management of IBC by @ABCGlobalAll lead by Fatima Cardoso. Register here https://t.co/ESKjr8w1bN https://t.co/ylxBVEpUxq
-
-
Mashup Score: 3cAttendee - 1 year(s) agoSource: cattendee.abstractsonline.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Don't forget that all sessions from #ESMOImmuno22 are available on-demand on the virtual platform until 12 December 2022 at 12:00 CET for all registered participants - so if you missed a great scientific or educational session head over here 👇 https://t.co/cQHZtVU6iM https://t.co/DWdj4Yj199
-
Benmelstobart and anlotinib + chemotherapy improve PFS (6.9 months vs. 4.2 months) and OS (19.3 months vs. 11.9 months) in Extensive stage SCLC https://t.co/6XDtGDpwzM https://t.co/1Ioqlo1fu0